Yttrium (90Y) tacatuzumab tetraxetan

Yttrium (⁹⁰Y) tacatuzumab tetraxetan is an investigational humanized monoclonal antibody intended for the treatment of cancer.^[1] The antibody itself, tacatuzumab, is conjugated with tetraxetan, a chelator for yttrium-90,^[2] a radioisotope which destroys the tumour cells.

Yttrium (⁹⁰Y) tacatuzumab tetraxetan

Monoclonal antibody
Type	Whole antibody
Source	Humanized (from mouse)
Target	α-fetoprotein
Clinical data
ATC code	none
Identifiers
CAS Number	476413-07-7 N
ChemSpider	none
UNII	GJ2416WK6Y
Chemical and physical data
Formula	C6470H9971N1712O2007S4290Y
Molar mass	145 kg/mol
NY (what is this?)  (verify)